REFERENCES

  1. Zimmermann (2017) Translating Myocardial Remuscularization. Circ Res 120(2):278-281.

  2. Fujita and Zimmermann (2017) Engineered heart repair. Clin Pharmacal Ther 102:197-199.

  3. Tiburcy et al. (2017) Defined Engineered Human Myocardium with Advanced Maturation for Applications in Heart Failure Modelling and Repair. Circulation 135:1832-1847.

  4. Qin et al. (2016) Magnetic Resonance Imaging of Cardiac Strain Pattern Following Transplantation of Human Tissue Engineered Heart Muscles. Circ Cardiovasc Imaging. 9(11 ). pii: e004731.

  5. Riegler et al. (2015) Human Engineered Heart Muscles Engraft and Survive Long-Term in a Rodent Myocardial Infarction Model. Circ Res 117:720-739.

  6. Tiburcy et al. (2014) Collagen-based Engineered Heart Muscle. Methods Mol Biol. 1181:167-76.

  7. Didié et al. (2013) Parthenogenetic Stem Cells for Tissue Engineered Heart Repair. J Clin Invest 123:1285-1298.

  8. Tiburcy M, et al. (2011) Terminal Differentiation, Advanced Organotypic Maturation, and Modeling of Hypertrophic Growth in Engineered Heart Tissue. Circ Res 109:1105-1114.

  9. Yildirim et al. (2007) Development of a Biological Ventricular Assist Device (BioVAD): Preliminary Data from a Small Animal Model. Circulation 116:116-23.

  10. Naito et al. (2006) Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle. Circulation 114:172-78.

  11. Zimmermann et al. (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12:452-458.





Repairon GmbH • Rudolf-Wissell-Str. 28a • 37079 Göttingen • Germany • info@repairon.de • www.repairon.de • © Repairon 2019